Glecaprevir/pibrentasvir and sofosbuvir/ velpatasvir/voxilaprevir have been approved by the FDA- update coming soon.
In addition to updates for all relevant sections in response to the new approvals, the following new sections will be released soon:
- HCV in Children
- HCV in Pregnancy
-
HCV Resistance Primer
FDA announcements:
- https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm570038.htm
-
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm567467.htm
Thursday, August 31, 2017